Procedure for the examination of body fluids for cancer cells, its use, corresponding analysis kits and use of certain active substances for the treatment of cancer
DE10215770A1
Detecting methylated and non-methylated cytosines, useful for assessing methylation status of cancer-associated gene promoters, by specific amplification and hybridization
WO0237113A2
Clinical and functional validation of targets from disseminated cancer cells
DE10109259A1
Characterizing increased dedifferentiation of cancer cells useful for diagnosing cancer, particularly early cervical cancer, comprises applying body fluids to a foil covered slide and detecting dye-marked cells by laser
DE10054632A1
A method for isolating disseminated cancer cells from a cell-containing body fluid and use of a filter device in such a method
DE10054635A1
Clinically validating target from disseminated cancer cells by determining whether status of target determined in cancer cells of individuals correlates with cancer-related information about clinical status of individuals
DE10041809A1
Arrays of immobilized biomolecules, their manufacture and use
DE10038080A1
Registering the presence of immobilized substances on a bio-chip carrier, comprises using a fluorescence scanner, where a pulsed laser excites fluorescent markings to be detected between the pulses with local resolution
DE10037506A1
Method for the detection of nucleic acids by means of hybridization, use of this method and corresponding analysis kit as well as nucleic acid oligomers and their use
DE10036457A1
Use of an imaging photoelectric area sensor for evaluating biochips and imaging processes therefor
DE19960500A1
Antibodies and processes for their preparation, their use and immunization cocktails, immunoassay sets and peptides
EP1007740A1
Method for characterizing disseminated and micrometastasized cancer cells
DE19833738A1
Procedures for isolating cancer cells from cell-containing body fluids and kits for performing this procedure
